Jennifer Anne Doudna
Doudna, Jennifer A.
Doudna, Jennifer A., 1964-....
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
Doudna, Jennifer
VIAF ID: 43652981 (Personal)
Permalink: http://viaf.org/viaf/43652981
Preferred Forms
-
200 _ | ‡a Doudna ‡b Jennifer A. ‡f 1964-....
-
200 _ 1 ‡a Doudna ‡b Jennifer A. ‡f 1964–
-
100 1 _
‡a
Doudna, Jennifer
-
100 1 _ ‡a Doudna, Jennifer A
-
100 1 _ ‡a Doudna, Jennifer A.
-
100 1 _ ‡a Doudna, Jennifer A.
-
100 1 _ ‡a Doudna, Jennifer A.
-
100 1 _ ‡a Doudna, Jennifer A.
-
100 1 _ ‡a Doudna, Jennifer A.
-
100 1 _ ‡a Doudna, Jennifer A.
-
100 1 _ ‡a Doudna, Jennifer A.
-
100 1 _
‡a
Doudna, Jennifer A.
-
100 1 _ ‡a Doudna, Jennifer A. ‡d (1964- )
-
100 1 _
‡a
Doudna, Jennifer A.
‡d
1964-
-
100 1 _
‡a
Doudna, Jennifer A.
‡d
1964-
-
100 1 _
‡a
Doudna, Jennifer A.,
‡d
1964-
-
100 1 _
‡a
Doudna, Jennifer A.,
‡d
1964-....
-
100 0 _
‡a
Jennifer Anne Doudna
4xx's: Alternate Name Forms (53)
5xx's: Related Names (1)
Works
| Title | Sources |
|---|---|
| Un coup de ciseaux dans la création : CRISPR-Cas9 : le redoutable pouvoir de contrôler l'évolution |
|
| Crack in creation |
|
| CRISPR-Cas : a laboratory manual |
|
| Edycja genów : władza nad ewolucją |
|
| Edytorzy genów |
|
| Eingriff in die Evolution die Macht der CRISPR-Technologie und die Frage, wie wir sie nutzen wollen |
|
| Hijacking the ribosome, 2001: |
|
| Mass spectrometric analysis of the human 40S ribosomal subunit: native and HCV IRES-bound complexes |
|
| Mass spectrometry reveals modularity and a complete subunit interaction map of the eukaryotic translation factor eIF3 |
|
| Mechanism of ribosome recruitment by hepatitis C IRES RNA |
|
| Mechanism of substrate selection by a highly specific CRISPR endoribonuclease. |
|
| Mechanisms of internal ribosome entry in translation initiation. |
|
| Methods to crystallize RNA. |
|
| Molecular biology : principles and practice |
|
| A molecular contortionist |
|
| Molecular mechanisms of RNA interference |
|
| Multiplexed RNA structure characterization with selective 2'-hydroxyl acylation analyzed by primer extension sequencing (SHAPE-Seq) |
|
| Mutational analysis of conserved nucleotides in a self-splicing group I intron |
|
| n2001128894 |
|
| Nucleosome breathing and remodeling constrain CRISPR-Cas9 function. |
|
| Optimized high-throughput screen for hepatitis C virus translation inhibitors. |
|
| Paul Sigler (1934-2000). |
|
| Perspective: Embryo editing needs scrutiny. |
|
| Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity |
|
| A phosphoramidate substrate analog is a competitive inhibitor of the Tetrahymena group I ribozyme. |
|
| Potent CRISPR-Cas9 inhibitors from Staphylococcus genomes |
|
| Precise and heritable genome editing in evolutionarily diverse nematodes using TALENs and CRISPR/Cas9 to engineer insertions and deletions |
|
| Preliminary X-ray diffraction studies of an RNA pseudoknot that inhibits HIV-1 reverse transcriptase |
|
| Preparation of homogeneous ribozyme RNA for crystallization |
|
| Profiling of engineering hotspots identifies an allosteric CRISPR-Cas9 switch |
|
| Programmable RNA recognition using a CRISPR-associated Argonaute. |
|
| Programmable RNA Tracking in Live Cells with CRISPR/Cas9. |
|
| Programmed DNA destruction by miniature CRISPR-Cas14 enzymes |
|
| Protecting genome integrity during CRISPR immune adaptation. |
|
| Quantitative studies of ribosome conformational dynamics. |
|
| Rapid detection of SARS-CoV-2 with Cas13 |
|
| Rational design of a split-Cas9 enzyme complex |
|
| Real-time observation of DNA recognition and rejection by the RNA-guided endonuclease Cas9. |
|
| Reassortment and mutation of the avian influenza virus polymerase PA subunit overcome species barriers |
|
| Receptor-Mediated Delivery of CRISPR-Cas9 Endonuclease for Cell Type Specific Gene Editing. |
|
| Reconsidering movement of eukaryotic mRNAs between polysomes and P bodies. |
|
| Reconstitution of selective HIV-1 RNA packaging in vitro by membrane-bound Gag assemblies. |
|
| Reply to Nathamgari et al.: Nanopore electroporation for intracellular delivery of biological macromolecules |
|
| Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression |
|
| Ribonuclease revisited: structural insights into ribonuclease III family enzymes |
|
| Ribozyme catalysis: not different, just worse. |
|
| Ribozyme-catalyzed primer extension by trinucleotides: a model for the RNA-catalyzed replication of RNA. |
|
| Ribozyme structures and mechanisms. |
|
| Ribozymes: the hammerhead swings into action |
|
| RNA-based recognition and targeting: sowing the seeds of specificity. |
|
| RNA binding and HEPN nuclease activation are decoupled in CRISPR-Cas13a |
|
| RNA-catalysed synthesis of complementary-strand RNA |
|
| RNA-dependent RNA targeting by CRISPR-Cas9. |
|
| RNA folds: insights from recent crystal structures |
|
| RNA-guided assembly of Rev-RRE nuclear export complexes |
|
| RNA-guided complex from a bacterial immune system enhances target recognition through seed sequence interactions. |
|
| RNA-guided genetic silencing systems in bacteria and archaea |
|
| RNA-mediated interaction between the peptide-binding and GTPase domains of the signal recognition particle. |
|
| RNA: primed for packing? |
|
| RNA processing enables predictable programming of gene expression. |
|
| RNA-programmed genome editing in human cells |
|
| RNA-protein analysis using a conditional CRISPR nuclease |
|
| RNA Scanning of a Molecular Machine with a Built-in Ruler. |
|
| RNA seeing double: close-packing of helices in RNA tertiary structure. |
|
| RNA structure, not sequence, determines the 5' splice-site specificity of a group I intron. |
|
| RNA tertiary structure mediation by adenosine platforms. |
|
| RNAs regulate biology. |
|
| Ro's role in RNA reconnaissance. |
|
| Selection of an RNA molecule that mimics a major autoantigenic epitope of human insulin receptor. |
|
| Selective stalling of human translation through small-molecule engagement of the ribosome nascent chain. |
|
| Self-assembly of a group I intron active site from its component tertiary structural domains. |
|
| Sequence- and Structure-Specific RNA Processing by a CRISPR Endonuclease |
|
| Single-Stranded DNA Cleavage by Divergent CRISPR-Cas9 Enzymes |
|
| siRNA repositioning for guide strand selection by human Dicer complexes. |
|
| Site-Specific Generation of Protein-Protein Conjugates Using Native Amino Acids |
|
| Solving large RNA structures by X-ray crystallography |
|
| Spacer Acquisition Rates Determine the Immunological Diversity of the Type II CRISPR-Cas Immune Response |
|
| A sparse matrix approach to crystallizing ribozymes and RNA motifs |
|
| A thermostable Cas9 with increased lifetime in human plasma |
|
| A Unified Resource for Tracking Anti-CRISPR Names |
|
| A universal mode of helix packing in RNA. |
|
| An unusual case of pseudo-merohedral twinning in orthorhombic crystals of Dicer |
|
| The use of CRISPR/Cas9, ZFNs and TALENs in generating site-specific genome alterations |
|
| (콕스) 분자생물학 |
|
| 크리스퍼가 온다 진화를 지배하는 놀라운 힘, 크리스퍼 유전자가위 |
|
